RecruitingPHASE2, PHASE3NCT06212336

ISTH/ANRS 0409s INTEGRATE Lassa Fever Study

Studying Lassa fever

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Irrua Specialist Teaching Hospital
Principal Investigator: Marie MD JASPARD, MD
ALIMA - The Alliance for International Medical Action - Paris, France
Intervention: Favipiravir(drug)
Enrollment: 1755 enrolled
Eligibility: 18 years · All sexes
Timeline: 2025 – 2027

Study locations (4)

Phebe Hospital, Suacoco, Bong County, Liberia
Irrua Specialist Teaching Hospital, Irrua, Edo, Nigeria
Federal Medical Center Owo, Owo, Ondo State, Nigeria
Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, Nigeria

Collaborators

Alliance for International Medical Action · University of Bordeaux · Bernhard Nocht Institute for Tropical Medicine · Federal Medical Centre, Owo · Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire · Fondation pour la Recherche Scientifique, Benin · Médecins Sans Frontières, Belgium · Alex Ekwueme Federal University Teaching Hospital · Donka Hospital, Conakry · Centre de Recherche Médicale de Lambaréné · University of Hamburg-Eppendorf · Phebe Hospital, Liberia · University of North Carolina · ANRS, Emerging Infectious Diseases

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06212336 on ClinicalTrials.gov

Other trials for Lassa fever

Additional recruiting or active studies for the same condition.

See all trials for Lassa fever →

← Back to all trials